- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02957916
Vanderbilt Childhood Obesity Registry (VCOR)
March 7, 2024 updated by: Ashley Shoemaker, Vanderbilt University Medical Center
In order to better understand early onset obesity and to identify patients in interested in future research studies, including clinical trials, we aim to develop a registry for patients with early onset obesity.
Study Overview
Status
Active, not recruiting
Detailed Description
Obesity is an epidemic effecting the pediatric population.
Currently, 17% of children are classified as obese and 32% as overweight.
Many of these children develop complications including type 2 diabetes, dyslipidemia, hypertension and hepatic steatosis.
Obesity is a global epidemic that lacks effective treatment options.
Obesity has many underlying causes including genetic predisposition and environmental factors.
Understanding the genetic basis of obesity may allow for more precisely targeted interventions including specific dietary plans and pharmacologic treatments.
The most common cause of genetic obesity is haploinsufficiency of the melanocortin-4 receptor (MC4R).
In obese adult cohorts, the prevalence of pathogenic MC4R mutations is 1-2%.
Commercial testing is available for many obesity syndromes, but the cost is high and charges are not always covered by insurance.
Clinicians have little motivation to test patients for MC4R mutations as no treatments are available and it is not clear if genetic testing results change patient behavior.
This particular lab and other groups are working to develop novel pharmacologic treatments for obesity syndromes, such as MC4R deficiency.
In order to better understand early onset obesity and to identify patients in interested in future research studies, including clinical trials, the investigators aim to develop a registry for patients with early onset obesity.
Study Type
Observational
Enrollment (Estimated)
3000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Tennessee
-
Nashville, Tennessee, United States, 37232
- Vanderbilt University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 years to 100 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Children with a history of excessive weight gain.
Description
Inclusion Criteria:
- BMI >97th percentile for age and gender before 6 years old
- Able to give written, informed consent/assent
Exclusion Criteria:
- Diagnosis of Prader-Willi syndrome
- Use of exogenous steroids or other medications known to cause abnormal weight gain
- Cushing's syndrome, untreated growth hormone deficiency or untreated hypothyroidism as an etiology for the obesity
- Hypothalamic obesity (obesity due to a brain tumor, head trauma or other brain lesion)
- Currently pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Other
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Prevalence of genetic mutations in DNA analysis
Time Frame: 5 years
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Ashley Shoemaker, MD, Vanderbilt University Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2012
Primary Completion (Estimated)
January 1, 2032
Study Completion (Estimated)
January 1, 2032
Study Registration Dates
First Submitted
October 31, 2016
First Submitted That Met QC Criteria
November 4, 2016
First Posted (Estimated)
November 8, 2016
Study Record Updates
Last Update Posted (Actual)
March 8, 2024
Last Update Submitted That Met QC Criteria
March 7, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 121345
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Data will be shared with collaborators and on a case by case basis.
Please contact Dr. Shoemaker for information.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatric Obesity
-
Virginia Commonwealth UniversityActive, not recruitingObesity, PediatricUnited States
-
University of British ColumbiaThe Hospital for Sick Children; Canadian Institutes of Health Research (CIHR); Alberta Health services and other collaboratorsCompleted
-
Hasselt UniversityJessa HospitalCompletedObesity, Pediatric
-
Azienda Ospedaliera Universitaria Integrata VeronaNot yet recruitingObesity, Pediatric
-
University of British ColumbiaHeart and Stroke Foundation of Canada; Public Health Agency of Canada (PHAC); Childhood Obesity Foundation and other collaboratorsCompleted
-
Columbia UniversityCompletedVitamin D Deficiency | Obesity, Morbid | Obesity, Childhood | Obesity, PediatricUnited States
-
University Hospital, Clermont-FerrandAME2P Laboratory, Clermont Auvergne UniversityCompleted
-
Medical College of WisconsinWisconsin Department of Health and Family Services; Children's Health System...TerminatedPediatric Obesity | Pediatric OverweightUnited States
-
Kahramanmaras Sutcu Imam UniversityCompletedPediatric Obesity | Pediatric DentistryTurkey
-
Central Hospital, Nancy, FranceNot yet recruiting